This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shimakura, S. Articles by Boland, C. R. Search for Related Content PubMed PubMed Citation Articles by Shimakura, S. Articles by Boland, C. R.

Eicosanoid Production by the Human Gastric Cancer Cell Line AGS and Its Relation to Cell Growth¹

Gastroenterology Section, VA Medical Center, and the Gastrointestinal Peptide Research Center, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48105

Eicosanoids have the ability to stimulate or inhibit the proliferation of epithelial cells, and they have been shown to modulate the growth characteristics of certain tumor cell lines. In addition, many epithelial cells have the ability to produce eicosanoids, which may then serve as autocrine growth factors. We have measured the eicosanoids produced by the human stomach cell line AGS using reverse-phase high-performance liquid chromatography. AGS cells were incubated with [³H]arachidonic acid and stimulated to release eicosanoids by the calcium ionophore A23187. Unlike its counterpart from the normal stomach, the AGS tumor cell line produced prominent amounts of the leukotrienes D₄, C₄, and B₄; 6-keto-prostaglandin F₁; thromboxane B₂; hydroxyeicosatetraenoic acids; and smaller amounts of other prostaglandins in response to A23187. Under basal condition (in the absence of calcium ionophore), hydroxyeicosatetraenoic acid was produced in greatest relative amount compared with the other eicosanoids.

To elucidate the potential autacoid role of these agents, exogenous eicosanoids were added to AGS cells, and proliferation was measured. Prostaglandins D₂ and E₂ suppressed the growth of AGS cells in a dose-dependent manner. On the other hand, leukotrienes D₄ and C₄ had a dose-dependent proliferative effect on cell growth. The lipoxygenase inhibitor nordihydroguaiaretic acid (10^–6, 10^–5 M) and hydrocortisone (10^–5 M) had dose-dependent suppressive effects on growth, whereas indomethacin (10^–4 M and 10^–5 M) had no effect. These results suggest that AGS cells preferentially metabolize arachidonic acid through the 5-lipoxygenase pathway, which results in the production of growth-stimulatory autocoids. Agents that selectively block this arm of eicosanoid metabolism might be useful therapeutic agents in the treatment of certain gastrointestinal cancers.

¹ Supported in part by NIH Grants R01DK37489 and P30-DK 34933 and by the Research Service of the Department of Veterans Affairs.

² To whom requests for reprints should be addressed, at GI Section (111D), VA Medical Center, 2215 Fuller Road, Ann Arbor, MI 48105.

Received 7/ 3/91. Accepted 1/17/92.

This article has been cited by other articles:

				Z.-Z. Zeng, C. R. Yellaturu, I. Neeli, and G. N. Rao 5(S)-Hydroxyeicosatetraenoic Acid Stimulates DNA Synthesis in Human Microvascular Endothelial Cells via Activation of Jak/STAT and Phosphatidylinositol 3-Kinase/Akt Signaling, Leading to Induction of Expression of Basic Fibroblast Growth Factor 2 J. Biol. Chem., October 18, 2002; 277(43): 41213 - 41219. [Abstract] [Full Text] [PDF]

				E. M. Grossman, W. E. Longo, N. Panesar, J. E. Mazuski, and D. L. Kaminski The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells Carcinogenesis, July 1, 2000; 21(7): 1403 - 1409. [Abstract] [Full Text] [PDF]